e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Stem cells and growth factors in lung injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Injury induced inflammasome activation leading to IL-1b and lung inflammation depends on IL-17
R. Bernhard (Orleans, France)
Source:
Annual Congress 2010 - Stem cells and growth factors in lung injury
Session:
Stem cells and growth factors in lung injury
Session type:
Oral Presentation
Number:
212
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Bernhard (Orleans, France). Injury induced inflammasome activation leading to IL-1b and lung inflammation depends on IL-17. Eur Respir J 2010; 36: Suppl. 54, 212
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Plasma surfactant protein D (SP-D) in patients (pts) with stable (S) COPD and during COPD acute exacerbation (AE)
Severe respiratory infection: when is ICU mandatory?
Comment on: Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
Related content which might interest you:
Hypoxia induces IL-18 and neutrophil influx in lung parenchyma possibly mediated by MIP-2
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
The role of pro-inflammatory cytokine activation in perioperative lung injury
Source: Annual Congress 2004 - Mechanisms and biomarkers of ischaemia-reperfusion-induced lung injury: lessons learnt from lung transplantation
Year: 2004
NLRP3 inflammasome conjugates with mitochondria in LPS-induced acute lung injury
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020
Late-breaking abstract: Activation of the macrophage inflammasome by TLR3 ligation potentiates release of IL-8 and IP-10 from alveolar type II epithelial cells via a paracrine cytokine network
Source: Annual Congress 2011 - Epithelial cells: role in health and disease
Year: 2011
Role of proinflammatory cytokines IL-18 and IL-1β in bleomycin-induced lung injury in humans and mice
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009
Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019
TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
A major inflammatory cytokine TNF-a inhibits the ventilatory response to hypoxia
Source: International Congress 2018 – Triggers of acute lung injury: mechanical ventilation and oxygen levels
Year: 2018
Activation of NLRP3 inflammasome is regulated by mitochondrial ROS via PI3K-HIF-VEGF pathway in acute lung injury
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015
Hypoxia induces inflammasome activation and influx of neutrophils and T-cells in the lungs
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013
Aerobic training modulates parenquimal inflammation
via
decreases of IL-4 and IL-5 release by inflammatory cells
Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel
in vitro
assays and results from animal models
Year: 2007
Late Breaking Abstract: IL-17 inhibits IL-23 release during airway inflammation
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
Exaggerated IL-6 responses to LPS after viral airway infection in mice is mediated by endogenous TNF-a production
Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens
Year: 2007
Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation
Source: Eur Respir J 2001; 18: Suppl. 33, 521s
Year: 2001
Elevated expression of the NLRP3 inflammasome in neutrophilic asthma
Source: Eur Respir J 2014; 43: 1067-1076
Year: 2014
Study of influence of interleukin-1b on cytokines production in inflammatory sites
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Decreased PTEN amplifies PI3K signaling and enhances pro-inflammatory cytokine release in COPD
Source: International Congress 2016 – Studies in airway cell biology
Year: 2016
Inflammation and remodeling modulated by anti IL17 in model of lung injury induced by elastase in mice
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Role of NLRP3 inflammasome and ATP in S100A12-induced MUC5AC production in airway epithelial cells
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018
LPS-induced TLR4 expression and cytokine release is impaired in monocytes and T-lymphocytes of COPD patients
Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept